Lancet: Towards a malaria vaccine -- serious investment needed

Apr 22, 2010

The lead Editorial in this week's Lancet, ahead of World Malaria Day on April 25, calls for 'serious investment into a 'broad research and development strategy towards a malaria vaccine'. The Editorial welcomes the vaccine in development by GSK, which could be ready by 2013, but notes its 'modest and time-limited efficacy'.

The Editorial says: "This has been in development for about 20 years and has cost GSK £300 million with an extra £200 million covered by the Bill & Melinda Gates Foundation. Earlier this year, Andrew Witty, GSK's Chief Executive, pledged to price the vaccine at just 5% above cost and invest profits back into research for diseases in developing countries. Although a welcome gesture, this commitment simply does not begin to go far enough. And here the global community has remained dismayingly silent."

It concludes: "Bill Gates has pledged $20 billion for the decade of vaccines. There must be greater public commitment by the pharmaceutical industry to support not only this personal pledge, but also the desperate cries from countries to help solve one of their greatest health predicaments. WHO, the Global Fund, UNICEF, and others must speak loudly and demand true public-private partnerships on a far larger scale. We cannot afford to wait a further 20 years...It is now, not tomorrow, that the global health community must show more ambition and accountability in combating malaria beyond its current control targets."

Explore further: Cooling of dialysis fluids protects against brain damage

add to favorites email to friend print save as pdf

Related Stories

Gates: $258 million for malaria research

Oct 31, 2005

The Bill and Melinda Gates Foundation has given $258 million in malaria research grants. The foundation says malaria kills an estimated 2,000 African children each day and takes the lives of more than 1 million people wor ...

Gates makes $10 billion vaccines pledge

Jan 29, 2010

(AP) -- The Bill and Melinda Gates Foundation will donate $10 billion over the next decade to research new vaccines and bring them to the world's poorest countries, the Microsoft co-founder and his wife said ...

New fund promises low-cost malaria treatment

Apr 19, 2009

(AP) -- A $225 million fund to provide low-price anti-malaria medicine around the world was launched in the Norwegian capital Friday to fight a disease that kills 2,000 children a day.

New malaria drug works in infants

Oct 19, 2007

Scientists say a new malaria vaccine being tested in Mozambique was successful in protecting infants less than 1 year old.

Recommended for you

Cooling of dialysis fluids protects against brain damage

1 hour ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

2 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments : 0